Core Laboratories sets October 28 results: Core Laboratories stock is 51.33 percent below its high

Published on 10/25/2026 at 01:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue fell 4.3 percent to USD 124.61 million. The USD 131.87 million Q3 estimate sets the test for Core Laboratories stock on October 28.

Earnings calendar and valuation

Core Laboratories announced the October 28 earnings release and October 29 call on October 1, 2026.
MarketBeat lists Q3 consensus revenue at USD 131.87 million and earnings per share at USD 0.1618.
Core Laboratories had a USD 454.7 million market capitalization as of October 23, 2026.

CLB, US21867A1051, Illustration mit AI erstellt.

Core Laboratories (US21867A1051) set October 28, 2026, for its third-quarter earnings release and October 29, 2026, for the conference call, according to Morningstar on October 1, 2026. The dates put the latest operating trend under the microscope after second-quarter revenue fell 4.3 percent year over year to USD 124.61 million.

The earnings test is approaching

MarketBeat expects Core Laboratories to report third-quarter revenue of USD 131.87 million and earnings per share of USD 0.1618. The revenue estimate is 1.97 percent below the USD 134.52 million reported for the same quarter a year earlier, while the earnings-per-share estimate is 26.45 percent below the prior-year USD 0.22.

The second-quarter result was more resilient on earnings than on sales. Core Laboratories reported diluted earnings per share of USD 0.13 for the quarter ended June 30, 2026, while net income was USD 5.96 million, according to the company's investor materials and the reported figures carried by MarketBeat.

Three dates show the earnings path

On October 22, 2025, Core Laboratories reported third-quarter revenue of USD 134.52 million and earnings per share of USD 0.22, according to Backpack Securities. On July 29, 2026, it reported second-quarter revenue of USD 124.61 million and earnings per share of USD 0.11, as reported by MarketBeat. On October 1, 2026, the company announced the October 28 release and October 29 call through Morningstar.

What does October 28 mean for margins?

The key comparison is the gap between the expected USD 131.87 million revenue and the prior-year USD 134.52 million. That forecast implies a smaller top line, while the USD 0.1618 earnings-per-share estimate points to a sharper year-over-year decline in profitability than in revenue.

The next two dates are fixed

Core Laboratories is scheduled to release third-quarter results after the market close on October 28, 2026, followed by its conference call at 8:30 a.m. ET on October 29, 2026, according to Morningstar.

NYSE valuation stays below annual high

Core Laboratories was last at USD 9.91 on the NYSE on October 23, 2026, at 4:00 p.m. EDT. Its 52-week range was USD 9.13 to USD 20.36, placing the price 51.33 percent below the high; market capitalization was USD 454.7 million on that date. The further course of trading is shown by the continuously updated real-time quote of Core Laboratories stock.